$327 Million is the total value of Tao Capital Management LP's 15 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 35.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TWST | Twist Bioscience Corporation | $64,142,000 | -27.7% | 828,815 | 0.0% | 19.60% | -17.0% | |
| OUST | Ouster, Inc. | $58,517,000 | -29.0% | 11,253,152 | 0.0% | 17.88% | -18.5% | |
| UBER | Uber Technologies, Inc. | $53,874,000 | -6.4% | 1,284,851 | 0.0% | 16.46% | +7.3% | |
| New | IonQ, Inc. | $34,286,000 | – | 2,053,047 | +100.0% | 10.48% | – | |
| TSLA | Sell | Tesla, Inc. | $30,383,000 | -31.9% | 28,750 | -50.0% | 9.28% | -21.9% |
| IS | ironSource Ltd.class a ordinary shares | $28,673,000 | -28.8% | 3,704,460 | 0.0% | 8.76% | -18.3% | |
| MASS | 908 Devices Inc. | $14,720,000 | -20.4% | 568,981 | 0.0% | 4.50% | -8.8% | |
| Benson Hill, Inc. | $12,938,000 | +2.2% | 1,774,681 | 0.0% | 3.95% | +17.3% | ||
| H | Hyatt Hotels Corporation | $6,713,000 | +24.4% | 70,000 | 0.0% | 2.05% | +42.6% | |
| MDGL | Buy | Madrigal Pharmaceuticals, Inc. | $6,581,000 | +60.5% | 77,657 | +51.1% | 2.01% | +84.0% |
| Sell | Warby Parker Inc. | $6,262,000 | -50.5% | 134,473 | -43.6% | 1.91% | -43.2% | |
| New | Bird Global, Inc. | $5,584,000 | – | 904,978 | +100.0% | 1.71% | – | |
| Joby Aviation, Inc. | $2,190,000 | -27.4% | 300,000 | 0.0% | 0.67% | -16.8% | ||
| ZY | Zymergen Inc. | $1,658,000 | -49.2% | 247,690 | 0.0% | 0.51% | -41.7% | |
| LAZR | New | Luminar Technologies, Inc. | $759,000 | – | 44,856 | +100.0% | 0.23% | – |
| SNSE | Exit | Sensei Biotherapeutics, Inc. | $0 | – | -32,784 | -100.0% | -0.09% | – |
| DNLI | Exit | Denali Therapeutics Inc. | $0 | – | -38,949 | -100.0% | -0.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Uber Technologies, Inc. | 16 | Q3 2023 | 58.6% |
| Twist Bioscience Corporation | 16 | Q3 2023 | 38.4% |
| Tesla, Inc. | 16 | Q3 2023 | 30.7% |
| Hyatt Hotels Corporation | 16 | Q3 2023 | 6.2% |
| Madrigal Pharmaceuticals, Inc. | 13 | Q3 2023 | 17.0% |
| 908 Devices Inc. | 12 | Q3 2023 | 10.0% |
| Ouster, Inc. | 10 | Q2 2023 | 32.3% |
| Benson Hill, Inc. | 9 | Q3 2023 | 4.0% |
| Warby Parker Inc. | 9 | Q3 2023 | 3.4% |
| Joby Aviation, Inc. | 7 | Q1 2023 | 1.0% |
View Tao Capital Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-12 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| SC 13D | 2023-06-08 |
| 13F-HR | 2023-05-10 |
| SC 13G/A | 2023-02-10 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View Tao Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.